GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InnoCare Pharma Ltd (OTCPK:INCPF) » Definitions » Net Margin %

InnoCare Pharma (InnoCare Pharma) Net Margin % : -49.76% (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is InnoCare Pharma Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. InnoCare Pharma's Net Income for the three months ended in Dec. 2023 was $-14.02 Mil. InnoCare Pharma's Revenue for the three months ended in Dec. 2023 was $28.18 Mil. Therefore, InnoCare Pharma's net margin for the quarter that ended in Dec. 2023 was -49.76%.

The historical rank and industry rank for InnoCare Pharma's Net Margin % or its related term are showing as below:

INCPF' s Net Margin % Range Over the Past 10 Years
Min: -334666.94   Med: -28693.38   Max: -6.19
Current: -57.82


INCPF's Net Margin % is ranked better than
60.64% of 1029 companies
in the Biotechnology industry
Industry Median: -157.22 vs INCPF: -57.82

InnoCare Pharma Net Margin % Historical Data

The historical data trend for InnoCare Pharma's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnoCare Pharma Net Margin % Chart

InnoCare Pharma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial -171,525.28 -28,637.80 -6.19 -141.76 -85.47

InnoCare Pharma Quarterly Data
Dec17 Sep18 Dec18 Jun19 Sep19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -200.77 -28.53 - -68.18 -49.76

Competitive Comparison of InnoCare Pharma's Net Margin %

For the Biotechnology subindustry, InnoCare Pharma's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InnoCare Pharma's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InnoCare Pharma's Net Margin % distribution charts can be found below:

* The bar in red indicates where InnoCare Pharma's Net Margin % falls into.



InnoCare Pharma Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

InnoCare Pharma's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-88.41/103.434
=-85.47 %

InnoCare Pharma's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-14.019/28.175
=-49.76 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


InnoCare Pharma  (OTCPK:INCPF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


InnoCare Pharma Net Margin % Related Terms

Thank you for viewing the detailed overview of InnoCare Pharma's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


InnoCare Pharma (InnoCare Pharma) Business Description

Traded in Other Exchanges
Address
No. 8 Life Science Park Road, Building 8, Zhongguancun Life Science Park, Changping District, Beijing, CHN, 102206
InnoCare Pharma Ltd is a commercial-stage biopharmaceutical company. It discovers, develops, and commercializes drugs for the treatment of cancer and autoimmune diseases. The company's main product pipeline includes orelabrutinib, ibrutinib, zanubrutinib, tafasitamab, ICP-490, ICP-B02, ICP-248, ICP-192, ICP-723, and ICP-189, among others. Its products are mainly used to treat hematological tumors, solid tumors, and autoimmune diseases. The company is also developing products for the treatment of autoimmune diseases caused by abnormal B-cell or T-cell function.